Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses:        
Research and development $ 449,679 $ 906,779 $ 791,221 $ 1,570,193
General and administrative 1,264,523 1,399,221 2,949,208 3,195,910
Total operating expenses 1,714,202 2,306,000 3,740,429 4,766,103
Loss from operations (1,714,202) (2,306,000) (3,740,429) (4,766,103)
Other income (expense):        
Interest income 16,793 6,405 26,996 25,640
Interest expense (572,310) (1,803) (771,437) (8,888)
Foreign currency exchange net (2,316) (3,692) (4,158) (6,572)
Total other (expense) income, net (557,833) 910 (748,599) 10,180
Net loss $ (2,272,035) $ (2,305,090) $ (4,489,028) $ (4,755,923)
Basic net loss per share $ (3.10) $ (15.27) $ (6.62) $ (35.56)
Diluted net loss per share $ (3.10) $ (15.27) $ (6.62) $ (35.56)
Weight-average shares outstanding, basic 731,817 150,968 677,800 133,752
Weight-average shares outstanding, diluted 731,817 150,968 677,800 133,752